Mechanism of Action of Pegcetacoplan
Introduction Pegcetacoplan is a targeted complement inhibitor used in diseases driven by abnormal activation of the complement system. It is marketed as Empaveli for systemic use and as Syfovre for intravitreal ophthalmic use. Empaveli is used for adult patients with paroxysmal nocturnal hemoglobinuria, commonly called PNH, and is also indicated for adults and pediatric patients … Read more
